Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3000 of 6351
-
Vibration and brain zaps show promise for stroke rehab
Symptom relief CompletedAlthough tDCS and FV have shown some benefit as stand-alone treatment, researcher suggest that combining intervention with complementary mechanism can lead to additive or synergistic benefits which might yield more significant improvement in functional outcome hence the author pr…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Phone apps aim to shield melanoma survivors from harmful UV rays
Prevention Recruiting nowThe purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure th…
Sponsor: Northwestern University • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
Practice makes perfect: could a fake breast help real moms breastfeed better?
Knowledge-focused CompletedBreastfeeding education provided by nurses is an important determinant of breastfeeding success and maternal breastfeeding self-efficacy. Nursing students should acquire effective breastfeeding counseling skills before entering clinical practice. Simulation-based education offers…
Sponsor: Izmir Katip Celebi University • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New allergy shots show promise for dust mite sufferers
Disease control CompletedHouse dust mites are the main source of allergies in indoor environments. They are predominant in coastal areas, with the Canary Islands being the autonomous community with the highest percentage of patients with rhinoconjunctivitis due to sensitisation to these mites (94.7%). I…
Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Herbal supplement ashwagandha tested for Women's sexual wellness
Symptom relief CompletedSexual health is a key part of a woman's overall physical, emotional, and mental well-being-even in the absence of any medical or psychological problems. It includes aspects such as sexual desire, arousal, satisfaction, and confidence in intimate relationships. Everyday factors l…
Sponsor: SF Research Institute, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Gut health hack: prebiotic may ease daily stress
Symptom relief OngoingThe levels of stress that we experience as a population are continuing to rise due to financial, social and work pressures, particularly in mid-life where additional factors such as family and career often compound these issues. When we experience high levels of stress for prolon…
Sponsor: University of Reading • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Online program aims to curb childhood obesity in Low-Income families
Prevention Recruiting nowThis study will evaluate the effects of two different approaches to support healthy family mealtime, sleep, and screentime routines: A parent leader-guided online program that promotes parent and child self-regulation as a means to improve healthy family routines versus an asynch…
Sponsor: University of Michigan • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
New study tracks pain changes in gender minority adults on hormone therapy
Knowledge-focused Recruiting nowTRANSPIRE is an observational study of \~200 individuals who (1) will be initiating gender-affirming hormone therapy (GHT) or (2) are gender minority individuals who do not use GHT. The primary outcome will be to identify how the presence of chronic pain changes overtime with GHT…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New drug CT-95 targets tough cancers in early trial
Disease control Recruiting nowThis is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamics, and antitumor activity of single-agent CT-95 in subjects with advanced (recurrent, unresectable, or metastatic) cancer…
Phase 1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Beetroot juice boosts exercise benefits for menopausal women
Symptom relief Recruiting nowThe purpose of this clinical study in women after menopause is to investigate whether the daily intake of nitrate from beetroot juice over 12 weeks enhances the positive effect of exercise training on vascular function, blood pressure and physical performance. The risk of cardio…
Sponsor: University of Vienna • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New online training aims to ease mental health struggles of doctors and nurses
Symptom relief CompletedThis randomized controlled trial (RCT) aims to evaluate the effectiveness of an online guided self-help intervention developed based on Problem Solving Therapy (PST) and Acceptance and Commitment Therapy (ACT), which are both transdiagnostic low-intensity interventions recommende…
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Music may soothe children in the emergency room
Symptom relief CompletedChildren presenting to the emergency department frequently experience anxiety and may undergo various painful procedures. While sedative agents are administered to these patients, they do not consistently provide adequate relief to keep the child calm and cooperative during the p…
Phase 3 • Sponsor: Tehran University of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Could a custom tumor map guide better ovarian cancer care?
Knowledge-focused Recruiting nowThe long-term goal of this research project is to demonstrate whether HRD negative (HPDneg) patients benefit when additional multi-modal biological tumor information is incorporated into the molecular tumor board (mTB) treatment recommendation process.
Sponsor: Swiss GO Trial Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Parkinson's pump study tracks Real-Life symptom control
Symptom relief Recruiting nowReal-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease
Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Acupuncture may restore periods lost to chemo in young cancer survivors
Symptom relief Recruiting nowThe purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers will look at how many participants enroll and complete the study. The researche…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Vitamin D3 and microneedling: a new hope for alopecia areata?
Disease control OngoingAlopecia areata is a common condition that causes sudden, patchy hair loss on the scalp and other body sites. It is believed to occur when the body's immune system mistakenly attacks the hair follicles, leading to hair loss that can range from small patches to more widespread inv…
Sponsor: Services Institute of Medical Sciences, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Shock and crunch: new combo therapy aims to restore balance after stroke
Symptom relief By invitation onlyTo evaluate the effects of the combining transcranial direct current stimulation with core stability exercises on trunk performance in poststroke hemiparetic patients, the secondary outcome is to evaluate the balance and the functional performance of the participants.
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Could a diabetes combo drug melt liver fat better than insulin alone?
Disease control OngoingThis is a single-center, randomized, open-label, controlled clinical trial to compare the effects of a fixed-ratio combination of insulin glargine 100 U/mL plus lixisenatide (iGlarLixi) versus insulin glargine 100 U/mL (iGlar) on liver fat content in patients with Type 2 Diabetes…
Phase 4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug shows promise for bipolar depression in early trial
Symptom relief OngoingThe goal of this clinical trial is to learn if ABX-002 added to participants' existing treatment(s) can improve clinical symptoms of depression and to learn about potential effects on brain chemistry that may correlate with antidepressive effects. This is a single treatment arm,…
Phase 2 • Sponsor: Autobahn Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Probiotic pill may ward off winter colds, study finds
Prevention CompletedThe goal of this study is to evaluate the efficacy of the LC-Plasma in preventing upper respiratory tract infections (URTIs) in healthy volunteers. Researchers will compare LC-Plasma to placebo to see if LC-Plasma prevents URTIs. Participants will take a tablet containing LC-Plas…
Phase 3 • Sponsor: RDC Clinical Pty Ltd • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC